Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control

Phase 4

Completed

• Conditions: Paroxysmal Supraventricular Tachycardia
• Interventions: Drug: Verapamil

• Registration Number: NCT01655316
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

PSVT is a common rhythm disorder in emergency department which can be recurrent in some cases.

Intravenous Adenosine is the drug of choice in PSVT control in acute settings but is a very short acting agent.

Providing a complementary medication to decrease the rate of recurrence of PSVT after its initial control will be promising.

This study evaluates the role of the oral Verapamil in recurrence control of PSVT in emergency situations.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-10
• Primary Completion: 2011-08
• Study Completion: 2011-08
• Study First Submitted: 2012-07-30
• Study First Submitted QC: 2012-07-31
• Study First Posted: 2012-08-01
• Status Verified: 2012-11
• Last Update Submitted: 2012-11-12
• Last Update Posted: 2012-11-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• Age>18 years old
• PSVT on emergency department presentation

Read More

Exclusion Criteria

• Instability in hemodynamic status
• Allergy to Verapamil

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Verapamil	Verapamil	40 mg Verapamil Per Oral

Primary Outcome Measures

Name	Time	Method
Recurrence Control	2 hours